Sorin Group is a global medical device company and a leader in the treatment of cardiovascular diseases.
With 3,900 employees worldwide, the Company develops, manufactures and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders.

Headquartered in Milan, Sorin is listed on the Stock Exchanges Milan.
Each year, more than one million patients are treated with Sorin devices in more than 100 countries.
Our life-saving products are in more than 5,000 hospitals worldwide.